Relay Therapeutics, Inc.

NASDAQ:RLAY

6.14 (USD) • At close November 7, 2024
Bedrijfsnaam Relay Therapeutics, Inc.
Symbool RLAY
Munteenheid USD
Prijs 6.14
Beurswaarde 997,510,540
Dividendpercentage 0%
52-weken bereik 5.6 - 12.14
Industrie Biotechnology
Sector Healthcare
CEO Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Website https://www.relaytx.com

An error occurred while fetching data.

Over Relay Therapeutics, Inc.

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth

Vergelijkbare Aandelen

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.31 USD

Bright Green Corporation logo

Bright Green Corporation

BGXX

0.076 USD

Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc.

AMPH

46.09 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

18.78 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

96.23 USD

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

17.67 USD

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

4.66 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)